Crescent Capital [CCAP] vs Brookfield [BN] Detailed Stock Comparison
Crescent Capital
NASDAQ
Loading...
Brookfield
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Crescent Capital wins in 12 metrics, Brookfield wins in 5 metrics, with 0 ties. Crescent Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crescent Capital | Brookfield | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.03 | 232.59 | Crescent Capital |
| Price-to-Book Ratio | 0.73 | 2.46 | Crescent Capital |
| Debt-to-Equity Ratio | 122.44 | 156.81 | Crescent Capital |
| PEG Ratio | -0.47 | 11.49 | Crescent Capital |
| EV/EBITDA | N/A | 14.75 | N/A |
| Profit Margin (TTM) | 24.12% | 0.73% | Crescent Capital |
| Operating Margin (TTM) | 75.45% | 27.05% | Crescent Capital |
| EBITDA Margin (TTM) | 75.45% | 27.05% | Crescent Capital |
| Return on Equity | 5.98% | 0.95% | Crescent Capital |
| Return on Assets (TTM) | 5.27% | 2.69% | Crescent Capital |
| Free Cash Flow (TTM) | $58.91M | $-3.60B | Crescent Capital |
| Dividend Yield | 15.89% | N/A | N/A |
| 1-Year Return | -22.24% | 29.40% | Brookfield |
| Price-to-Sales Ratio (TTM) | 2.90 | 1.24 | Brookfield |
| Enterprise Value | $1.41B | $455.84B | Brookfield |
| EV/Revenue Ratio | 7.69 | 5.45 | Brookfield |
| Gross Profit Margin (TTM) | N/A | 38.73% | N/A |
| Revenue per Share (TTM) | $5 | $55 | Brookfield |
| Earnings per Share (Diluted) | $1.19 | $0.29 | Crescent Capital |
| Beta (Stock Volatility) | 0.60 | 2.19 | Crescent Capital |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Crescent Capital vs Brookfield Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crescent Capital | -0.56% | -6.20% | -10.67% | -0.70% | -15.70% | -25.92% |
| Brookfield | 0.81% | 0.42% | 5.16% | 6.86% | 36.46% | 19.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crescent Capital | -22.24% | 4.79% | 13.03% | -13.23% | -13.23% | -13.23% |
| Brookfield | 29.40% | 110.25% | 141.60% | 286.01% | 672.89% | 1,024.55% |
News Based Sentiment: Crescent Capital vs Brookfield
Crescent Capital
News based Sentiment: POSITIVE
The month of October 2025 presented a positive outlook for CCAP, driven by strong Style Scores from Zacks and a potential price move alert. While Investing.com noted limited growth, the overall narrative suggests a compelling opportunity for income-focused investors.
Brookfield
News based Sentiment: POSITIVE
Despite a slight earnings miss, Brookfield demonstrated strong fundraising success, expanded into a new market with the Japanese reinsurance agreement, and secured significant financing deals. Analyst sentiment remains largely positive, suggesting a continued belief in the company's long-term growth prospects.
Performance & Financial Health Analysis: Crescent Capital vs Brookfield
| Metric | CCAP | BN |
|---|---|---|
| Market Information | ||
| Market Cap | $553.03M | $103.45B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 233,710 | 2,772,840 |
| 90 Day Avg. Volume | 218,490 | 2,169,097 |
| Last Close | $14.23 | $68.71 |
| 52 Week Range | $13.54 - $20.19 | $43.61 - $74.20 |
| % from 52W High | -29.52% | -7.40% |
| All-Time High | $21.24 (Oct 11, 2021) | $74.20 (Sep 23, 2025) |
| % from All-Time High | -33.00% | -7.40% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | -0.22% |
| Quarterly Earnings Growth | -0.26% | -0.28% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 0.01% |
| Operating Margin (TTM) | 0.75% | 0.27% |
| Return on Equity (TTM) | 0.06% | 0.01% |
| Debt to Equity (MRQ) | 122.44 | 156.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.55 | $27.44 |
| Cash per Share (MRQ) | $0.26 | $8.32 |
| Operating Cash Flow (TTM) | $65.36M | $8.95B |
| Levered Free Cash Flow (TTM) | $58.51M | $-2,725,499,904 |
| Dividends | ||
| Last 12-Month Dividend Yield | 15.89% | N/A |
| Last 12-Month Dividend | $2.41 | N/A |
Valuation & Enterprise Metrics Analysis: Crescent Capital vs Brookfield
| Metric | CCAP | BN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.03 | 232.59 |
| Forward P/E | 7.08 | 11.49 |
| PEG Ratio | -0.47 | 11.49 |
| Price to Sales (TTM) | 2.90 | 1.24 |
| Price to Book (MRQ) | 0.73 | 2.46 |
| Market Capitalization | ||
| Market Capitalization | $553.03M | $103.45B |
| Enterprise Value | $1.41B | $455.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.69 | 5.45 |
| Enterprise to EBITDA | N/A | 14.75 |
| Risk & Other Metrics | ||
| Beta | 0.60 | 2.19 |
| Book Value per Share (MRQ) | $19.55 | $27.44 |
Financial Statements Comparison: Crescent Capital vs Brookfield
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CCAP | BN |
|---|---|---|
| Revenue/Sales | $7.13M | $17.94B |
| Cost of Goods Sold | N/A | $11.00B |
| Gross Profit | N/A | $6.95B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $4.48B |
| EBITDA | N/A | $8.23B |
| Pre-Tax Income | $4.41M | $598.00M |
| Income Tax | $501,000 | $383.00M |
| Net Income (Profit) | $3.90M | $215.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CCAP | BN |
|---|---|---|
| Cash & Equivalents | $12.03M | $12.44B |
| Total Current Assets | N/A | $65.21B |
| Total Current Liabilities | N/A | $58.80B |
| Long-Term Debt | $902.95M | $245.86B |
| Total Shareholders Equity | $727.12M | $158.93B |
| Retained Earnings | $-232.01M | N/A |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CCAP | BN |
|---|---|---|
| Operating Cash Flow | $2.00M | $3.48B |
| Capital Expenditures | N/A | $-1.83B |
| Free Cash Flow | $-15.13M | $4.00M |
| Debt Repayment | $-233.04M | $-20.53B |
| Common Stock Repurchase | N/A | $-136.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CCAP | BN |
|---|---|---|
| Shares Short | 193,934 | 15.19M |
| Short Ratio | 0.90 | 8.18 |
| Short % of Float | 0.01% | N/A |
| Average Daily Volume (10 Day) | 233,710 | 2,772,840 |
| Average Daily Volume (90 Day) | 218,490 | 2,169,097 |
| Shares Outstanding | 37.06M | 1.51B |
| Float Shares | N/A | 1.17B |
| % Held by Insiders | 0.03% | 0.18% |
| % Held by Institutions | 0.65% | 0.58% |
Dividend Analysis & Yield Comparison: Crescent Capital vs Brookfield
| Metric | CCAP | BN |
|---|---|---|
| Last 12-Month Dividend | $2.41 | N/A |
| Last 12-Month Dividend Yield | 15.89% | N/A |
| 3-Year Avg Annual Dividend | $2.04 | N/A |
| 3-Year Avg Dividend Yield | 1.66% | N/A |
| 3-Year Total Dividends | $6.13 | N/A |
| Ex-Dividend Date | Sep 30, 2025 | N/A |